Search Results

Site Search

Staying the course through follow-up care and therapeutic drug monitoring: Billy Dowell Jr. - Insights

For Billy Dowell Jr., a competitive golfer, focus, determination, and course correction are essential to excelling at the sport. These skills, along with routine follow-up care and testing, are also important to navigating a life impacted...

CPT codes and LOINC update: March 2021 - Insights

The following list includes updates posted to mayocliniclabs.com during the month of March.

Patient-focused pragmatism: The Mayo Clinic innovation model - Insights

In a world of ever-faster technical change, Mayo Clinic Laboratories is uniquely positioned to innovate. Collaboration with clinicians pinpoints unmet patient needs and facilitates the development of diagnostic testing that provides...

Carbohydrate metabolism - Insights

Learn more about how Mayo Clinic Laboratories testing for carbohydrate metabolism can identify genetic variants and confirm diagnosis of these complex conditions.

Demyelinating disease - Insights

Learn about our demyelinating disease testing, including multiple sclerosis, AQP4/MOG-associated disorders, and spinal cord disorders.

Specialized testing diagnoses uncommon allergy to red meat: Joseph Ducaji - Insights

CT scans and hiatal/abdominal ultrasounds could not uncover why, whenever he ate steak, Joseph Ducaji experienced severe stomach problems, itchy hives, chills, and nausea. It took specialized testing from Mayo Clinic to unlock a...

Chromium and Cobalt - Insights

Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' synovial fluid testing for patients with symptoms of failed hip arthroplasty. The Food and Drug Administration recommends testing for elevated chromium and cobalt, which can indicate...

Urologic cancer - Insights

Learn about how our testing for patients with renal, bladder, and prostate cancer identifies the cancer’s genetic traits and helps direct treatment.

Mood disorders - Insights

Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.

March 2023 - Hematopathology & Laboratory Genetics and Genomics - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case's sub-specialties are Hematopathology and Laboratory Genetics and Genomics.